Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Trump’s pardons included health care execs behind massive frauds

At the last minute, President Donald Trump granted pardons to several individuals convicted in huge Medicare swindles that prosecutors alleged often harmed or endangered elderly and infirm patients while fleecing taxpayers.

22 Jan 2021

Pioneering new eye test may predict wet AMD three years before symptoms develop

A pioneering new eye test, developed by scientists at UCL in collaboration with the Western Eye Hospital, London, may predict wet AMD, a leading cause of severe sight loss, three years before symptoms develop.

18 Dec 2020

Researchers develop first biohybrid artificial retina with silk fibroin and retinal cells

An international research led by the Complutense University of Madrid has taken a further step to solve the age-related macular degeneration (AMD)-derived blidness problem with the development of the first biohybrid artificial retina built with silk fibroin and retinal cells.

11 Dec 2020

Research reveals insights into potential drivers of 'wet' age-related macular degeneration

"Wet" age-related macular degeneration (AMD) is one of the most common causes of irreversible vision loss in the elderly, and it occurs when abnormal and leaky blood vessels form in the retina, in part due to inflammation.

11 Dec 2020

$3-year-old children have adult-like preference for visual fractal patterns$

3-year-old children have adult-like preference for visual fractal patterns

By the time children are 3 years old they already have an adult-like preference for visual fractal patterns commonly seen in nature, according to University of Oregon researchers.

11 Dec 2020

RetinAI collaborates with Novartis to provide AI solutions for ophthalmology projects

RetinAI Medical AG announces a multi-year collaboration with Novartis Pharma AG under which RetinAI’s IT solutions and artificial intelligence tools shall be employed to support multiple projects in ophthalmology and digital health. Both companies have previously worked successfully on pilot projects in this disease area.

10 Dec 2020

Study: Global public health services fail to meet targets to reduce avoidable sight loss

A new global study has found no significant reduction in the number of people with treatable sight loss since 2010.

3 Dec 2020

Researchers use new imaging technique to produce digital reconstruction of eye tissues

A new study by scientists at the University of Southampton has made a breakthrough that could help the search for treatments against age related sight loss.

2 Dec 2020

Researchers find way for customized programming of human stem cells

Induced pluripotent stem cells (iPS) have the potential to convert into a wide variety of cell types and tissues for drug testing and cell replacement therapies. However, the "recipes" for this conversion are often complicated and difficult to implement.

30 Nov 2020

UB researchers uncover new functions in ataxin 3 gene that causes Machado-Joseph disease

Ataxia is a minority disease with genetic origins, known for its neuromuscular alterations due to the selective loss of neurons in the cerebellum, the organ of our nervous systems which controls movement and balance.

25 Nov 2020

LOX plays a number of key roles in promoting skin and organ fibrosis in scleroderma

A team of researchers at the Medical University of South Carolina (MUSC) has found that the molecule lysyl oxidase (LOX) plays a number of important roles in promoting skin and organ fibrosis in scleroderma, a connective tissue disorder.

17 Nov 2020

An acebuchin-oil-enriched diet helps to reduce arterial blood pressure

An acebuchin-oil-enriched diet helps to reduce arterial blood pressure, as shown by a study carried out by the Cardiovascular Physiopathology research group at the Physiology Department of the University of Seville.

17 Nov 2020

Pioneering stem cell research may help restore sight to people with macular diseases

Eye research charity Fight for Sight has announced funding for a ground-breaking stem cell research study which could reverse sight loss for people with macular diseases such as age-related macular degeneration and juvenile macular dystrophies.

12 Nov 2020

Postdoctoral fellow at LSU Health New Orleans becomes first NIH Outstanding Scholar

Khanh Do, PhD, a postdoctoral fellow at LSU Health New Orleans Neuroscience Center of Excellence, is a member of the first group chosen by the National Institutes of Health (NIH) as NIH Outstanding Scholars in Neuroscience.

11 Nov 2020

Study: Coronaviruses are adept at imitating human immune proteins involved in COVID-19

Coronaviruses are adept at imitating human immune proteins that have been implicated in severe COVID-19 disease, a study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found.

28 Oct 2020

Scripps Research scientists uncover potential new strategy for treating eye diseases

Scientists at Scripps Research have uncovered a potential new strategy for treating eye diseases that affect millions of people around the world, often resulting in blindness.

27 Oct 2020

Common medication used to treat diabetic macular edema is less effective in Black patients

A medication frequently used to treat diabetic macular edema, which is the most common cause of blindness in people with diabetes, is less effective when used to treat the condition in Black patients, new study results show.

22 Oct 2020

Newly developed light-sensing protein restores vision in blind mice

A newly developed light-sensing protein called the MCO1 opsin restores vision in blind mice when attached to retina bipolar cells using gene therapy.

22 Oct 2020

Researchers design new ocular insert to administer antioxidants in the eye

Researchers from Valencia’s CEU Cardenal Herrera University have published their study on this new way to administer glutathione for the treatment of ocular diseases linked to oxidative stress in journal Pharmaceutics.

21 Oct 2020

FAU researchers receive NIH funding to analyze stem cell activation

Researchers from Florida Atlantic University's Schmidt College of Medicine hope to conquer a major limitation in the ability for scientists to engineer tissues for regenerative therapies for age-related and degenerative diseases.

14 Oct 2020

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Trump’s pardons included health care execs behind massive frauds

Pioneering new eye test may predict wet AMD three years before symptoms develop

Researchers develop first biohybrid artificial retina with silk fibroin and retinal cells

Research reveals insights into potential drivers of 'wet' age-related macular degeneration

3-year-old children have adult-like preference for visual fractal patterns

RetinAI collaborates with Novartis to provide AI solutions for ophthalmology projects

Study: Global public health services fail to meet targets to reduce avoidable sight loss

Researchers use new imaging technique to produce digital reconstruction of eye tissues

Researchers find way for customized programming of human stem cells

UB researchers uncover new functions in ataxin 3 gene that causes Machado-Joseph disease

LOX plays a number of key roles in promoting skin and organ fibrosis in scleroderma

An acebuchin-oil-enriched diet helps to reduce arterial blood pressure

Pioneering stem cell research may help restore sight to people with macular diseases

Postdoctoral fellow at LSU Health New Orleans becomes first NIH Outstanding Scholar

Study: Coronaviruses are adept at imitating human immune proteins involved in COVID-19

Scripps Research scientists uncover potential new strategy for treating eye diseases

Common medication used to treat diabetic macular edema is less effective in Black patients

Newly developed light-sensing protein restores vision in blind mice

Researchers design new ocular insert to administer antioxidants in the eye

FAU researchers receive NIH funding to analyze stem cell activation

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in